Compounds > nad
Page last updated: 2024-08-17

nad and ciglitazone

nad has been researched along with ciglitazone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, H; Tai, HH2
Botta, G; Bottoni, P; Giardina, B; Martorana, GE; Pastore, P; Scatena, R; Vincenzoni, F1

Other Studies

3 other study(ies) available for nad and ciglitazone

ArticleYear
Thiazolidinediones as a novel class of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors.
    Archives of biochemistry and biophysics, 2002, Sep-15, Volume: 405, Issue:2

    Topics: Drug Evaluation, Preclinical; Enzyme Inhibitors; Hydroxyprostaglandin Dehydrogenases; Imipramine; Kinetics; NAD; Structure-Activity Relationship; Thiazoles; Thiazolidinediones

2002
Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
    Prostaglandins, leukotrienes, and essential fatty acids, 2002, Volume: 67, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Hydroxyprostaglandin Dehydrogenases; Inhibitory Concentration 50; Isoenzymes; Kinetics; Membrane Proteins; NAD; Placenta; Prostaglandin-Endoperoxide Synthases; Thiazoles; Thiazolidinediones

2002
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology.
    European journal of pharmacology, 2007, Jul-12, Volume: 567, Issue:1-2

    Topics: Cell Line, Tumor; Cell Proliferation; Humans; Hypoglycemic Agents; Ligands; Liver; Mitochondria; NAD; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Thiazolidinediones

2007